Cargando…

Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()

Detalles Bibliográficos
Autores principales: Crespo Burillo, J.A., Loriente Martínez, C., García Arguedas, C., Mora Pueyo, F.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316086/
https://www.ncbi.nlm.nih.gov/pubmed/34330677
http://dx.doi.org/10.1016/j.nrleng.2021.05.002
_version_ 1783729810880593920
author Crespo Burillo, J.A.
Loriente Martínez, C.
García Arguedas, C.
Mora Pueyo, F.J.
author_facet Crespo Burillo, J.A.
Loriente Martínez, C.
García Arguedas, C.
Mora Pueyo, F.J.
author_sort Crespo Burillo, J.A.
collection PubMed
description
format Online
Article
Text
id pubmed-8316086
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-83160862021-07-28 Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine() Crespo Burillo, J.A. Loriente Martínez, C. García Arguedas, C. Mora Pueyo, F.J. Neurologia (Engl Ed) Letter to the Editor Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2021-09 2021-07-28 /pmc/articles/PMC8316086/ /pubmed/34330677 http://dx.doi.org/10.1016/j.nrleng.2021.05.002 Text en © 2021 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Crespo Burillo, J.A.
Loriente Martínez, C.
García Arguedas, C.
Mora Pueyo, F.J.
Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
title Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
title_full Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
title_fullStr Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
title_full_unstemmed Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
title_short Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
title_sort amyotrophic neuralgia secondary to vaxzevri (astrazeneca) covid-19 vaccine()
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316086/
https://www.ncbi.nlm.nih.gov/pubmed/34330677
http://dx.doi.org/10.1016/j.nrleng.2021.05.002
work_keys_str_mv AT crespoburilloja amyotrophicneuralgiasecondarytovaxzevriastrazenecacovid19vaccine
AT lorientemartinezc amyotrophicneuralgiasecondarytovaxzevriastrazenecacovid19vaccine
AT garciaarguedasc amyotrophicneuralgiasecondarytovaxzevriastrazenecacovid19vaccine
AT morapueyofj amyotrophicneuralgiasecondarytovaxzevriastrazenecacovid19vaccine